Milos Miljkovic

Milos Miljkovic

Nessuna posizione attualmente

Patrimonio netto: - $ in data 30/04/2024

40 anni
Commercial Services

Provenienza dei contatti di primo grado di Milos Miljkovic

EntitàTipo di entitàSettore Industriale
4
Subsidiary Miscellaneous Commercial Services 4

Grafico delle società connesse in secondo grado

Relazione in diverse aziende

Società connesse a Milos Miljkovic tramite i suoi contatti personali

SocietàSettorePersone collegatePosizione principale
LIGAND PHARMACEUTICALS INCORPORATED Pharmaceuticals: Major

Nishan de Silva

Director of Finance/CFO

Investment Managers

Nishan de Silva

Private Equity Investor

ARQULE, INC. Pharmaceuticals: Major

Patrick Zenner

Timothy Barabe

Chairman

Director/Board Member

Pharmaceuticals: Major

Nishan de Silva

Director/Board Member

INSMED INCORPORATED Pharmaceuticals: Major

Blaine Davis

Investor Relations Contact

AEROCRINE AB Electronic Equipment/Instruments

Scott Myers

Chief Executive Officer

Bayer Pharmaceuticals Corp.

Carsten Brunn

Corporate Officer/Principal

Miscellaneous Commercial Services

Patrick Zenner

Carsten Brunn

Director/Board Member

Director/Board Member

Industrial Specialties

Aymeric Sallin

Director/Board Member

Biotechnology

Nishan de Silva

Director/Board Member

Miscellaneous Commercial Services

Aymeric Sallin

Director/Board Member

Investment Managers

Nishan de Silva

Corporate Officer/Principal

Miscellaneous Commercial Services

Nishan de Silva

Corporate Officer/Principal

Miscellaneous Commercial Services

Aymeric Sallin

Corporate Officer/Principal

University of Freiburg College/University

Carsten Brunn

Graduate Degree

École Polytechnique Fédérale de Lausanne College/University

Aymeric Sallin

Graduate Degree

Pharmaceuticals: Major

Carsten Brunn

President

OREXO AB Pharmaceuticals: Major

Scott Myers

Director/Board Member

Pharmaceuticals: Major

Nishan de Silva

Director/Board Member

College/University

Scott Myers

Undergraduate Degree

The Johns Hopkins University College/University

Emily English

Chief Executive Officer

University of Wisconsin College/University

Murat Kalayoglu

Emily English

Chris Jewell

Doctorate Degree

Doctorate Degree

Doctorate Degree

University of Maryland College/University

Emily English

Chris Jewell

Undergraduate Degree

Corporate Officer/Principal

University of Hamburg College/University

Carsten Brunn

Doctorate Degree

Semiconductors

Aymeric Sallin

Director/Board Member

Investment Managers

Aymeric Sallin

Chief Executive Officer

NanoDimension AG

Aymeric Sallin

Chief Executive Officer

Pharmaceuticals: Major

Murat Kalayoglu

Michael Singer

Founder

Founder

VIEW, INC. Industrial Specialties

Aymeric Sallin

Director/Board Member

Biotechnology

Aymeric Sallin

Director/Board Member

Swiss Academy of Technical Sciences

Aymeric Sallin

Corporate Officer/Principal

Young Global Leaders

Aymeric Sallin

Corporate Officer/Principal

PROTARA THERAPEUTICS, INC. Pharmaceuticals: Major

Blaine Davis

Director of Finance/CFO

Pharmaceuticals: Major

Nishan de Silva

Director/Board Member

Perelman School of Medicine College/University

Nishan de Silva

Doctorate Degree

The Wharton School of the University of Pennsylvania College/University

Nishan de Silva

Masters Business Admin

Harvard College College/University

Nishan de Silva

Undergraduate Degree

POSEIDA THERAPEUTICS, INC. Biotechnology

Nishan de Silva

President

Miscellaneous Commercial Services

Nishan de Silva

Director/Board Member

Miscellaneous Commercial Services

Nishan de Silva

Chief Executive Officer

Biotechnology

Timothy Springer

Founder

Biotechnology

Michael Singer

Director/Board Member

Biotechnology

Emily English

Chief Executive Officer

Statistiche

Distribuzione geografica

Stati Uniti 38
Svizzera 4
Svezia 3
Germania 3
Canada 2

Settori

Health Technology 21
Consumer Services 11
Commercial Services 9
Finance 4
Electronic Technology 3

Posizioni

Director/Board Member 85
Corporate Officer/Principal 31
Independent Dir/Board Member 24
Chairman 22
Chief Executive Officer 21
-40% Offerta a tempo limitato: i nostri abbonamenti ti guidano verso i migliori investimenti di domani.
APPROFITTANE ORA